Telum Therapeutics is a biotechnology company.
Telum Therapeutics has raised €22M across 2 funding rounds from 8 investors, most recently a Series A round in Jul 2026. Based in Pamplona, Spain; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-07-01 | Series A | €18M | CDTI,Clave Capital,Inveready,Invivo Partners,SICC Innvierte fund,Sodena+1 more | View deal → |
| 2020-07-14 | Seed | €4.1M | Invivo Capital Partners | View deal → |
